● Recruiting

Dexmedetomidine as an Adjuvant to Bupivacaine in Scalp Block Versus Bupivacaine Alone for Postoperative Pain Management in Patients Undergoing Craniotomy

Condition: Dexmedetomidine · Adjuvant · Bupivacaine · Sponsor: Ain Shams University

PhaseNA

Planned participants50

Who can joinAll sexes, 18 Years to 65 Years

Healthy volunteersNo

About this study

This study aims to compare dexmedetomidine as an adjuvant to bupivacaine in scalp block versus bupivacaine alone for postoperative pain management in patients undergoing craniotomy.

This description comes directly from the study's public registry record.

Talk to the study team

Omar A Khiralla, MBBCH · 00201095281838 · Omar-Ahmed@med.asu.edu.eg

Always discuss trial participation with your own doctor first.

Locations (1)

Ain Shams University

Cairo, Egypt

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06993922